Solutions · For Quality and Safety

Check the site and the supplier before the inspector does

Workbench builds inspection preparation plans and supplier qualification checklists from EU GMP guidance, and reviews your own records against it with every finding cited. Alerts watches GMP updates from the agencies you follow.

Workbench · site qualification

What the evidence covers, and what it does not

2 gaps

Site B · contract manufacturer

1 covered · 2 gaps · 1 to recheck

  • GMP certificate

    ✓

    Scope covers non-sterile tablets

    Covered

  • Quality agreement

    !

    Testing and release of materials not assigned

    Gap

  • Audit of the site

    !

    Not in the documents supplied

    Gap

  • EudraGMDP record

    ↻

    Look again before filing for a newer certificate

    Recheck

The same check feeds the variation that adds the site, so the certificate is confirmed before the submission is drafted.

The problem

Site evidence is scattered, and gaps surface late

A GMP certificate sits in EudraGMDP, the quality agreement in a shared drive and the contamination control strategy in the site's own system. Whether they cover what the dossier claims is often checked only when a variation is already drafted or an inspection is already announced.

Built on the source

Every line traced to its source

Answers are written from the sources retrieved for the question, not from model memory. Here is a CMC answer, claim by claim.
The answer
  1. Tightening the limit is a Type IA variation in the EU. [2]

  2. Notify within 12 months of implementing it. [1]

  3. In the US it goes in the annual report. [5]

  4. The approved limit is Q = 75% at 45 min. [D1]

Where it came from
  1. [1]
    Regulation (EC) No 1234/2008Article 8 · Type IA notifications
    EUR-Lex
  2. [2]
    Variations classification guidelineChanges to finished product specifications
    EudraLex
  3. [5]
    Changes to an approved NDA or ANDASpecifications · annual report changes
    FDA Guidance
  4. [D1]
    change-control-cc-2291.pdfPage 3 · current dissolution limit
    Your document
What it searches
  • US FDA 8
  • EU & EMA 9
  • ICH & standards 6
  • National agencies 5
  • Global regulators 4
  • Terminology 4
  • HTA bodies 3
  • Clinical & literature 2
  • Your documents
How it works

From a checklist to a gap table

Workbench builds the checklist

Start from a quick task: an eight-week preparation plan for an EU GMP inspection, or a qualification checklist for a contract manufacturer. Workbench cites the guidance behind each item.

Workbench reads your records

Attach the certificate, the agreement, a contamination control strategy or a CAPA record. Workbench lists the gaps with the document reference and the guidance section, and says what needs evidence from the site.

Alerts watches GMP updates

Alerts reads GMP notices against your registrations. PMDA's wider document requests for remote inspections were filed for reference, because Ostra holds no registrations in Japan.

In Workbench

Qualify a contract manufacturer

Site B is proposed as a second manufacturing site for Atorvastatin Ostra 20 mg. Workbench checks its GMP certificate and the draft quality agreement before the variation is filed.

Workbench+ New Chat
History Site B qualification check Sources
You09:14 AM

Site B will manufacture Atorvastatin Ostra 20 mg tablets. Check the attached GMP certificate and draft quality agreement against EU GMP expectations for a contract manufacturer. What is missing before we qualify the site?

site-b-gmp-certificate.pdfReady
Regunaut09:14 AM
  1. understanding your question…

    Site B · contract manufacturer · non-sterile tablets

Warning details⌄
  • A certificate shows the outcome of one inspection. It does not replace your own audit of the site.

1. Short answer

The certificate covers the dosage form. Two gaps remain: the agreement does not say who tests and releases starting materials, and the documents include no audit of Site B.

2. Qualification evidence

ElementFinding
Certificate scopeCovers non-sterile tablets [D1]
Testing and release of materialsNot assigned in the agreement [D2]
Audit of the siteNot in the documents supplied [1]

3. Before qualifying the site

  • Assign testing and release of starting materials in the agreement.
  • Schedule the audit of Site B, or attach the report if one exists.
  • Check EudraGMDP again before filing, in case a newer certificate or a non-compliance statement is published.
Citations (5)⌄
Helpful? Copy PDF
Example response · Condensed for this product demonstration
Ask a follow-up question...↑
In the platform today

The jobs teams run for this

Each of these is a quick task in Workbench or a tool with a screen of its own. Picking a quick task writes the prompt for you; add your product and market, and the answer comes back with its sources.

  • Workbench quick task · CMCUses your documents

    Assess a manufacturing site change

    Map the proposed transfer to filing options and evidence needs.

    See the prompt

    Using the attached change proposal and approved CMC sections, assess the EU variation route for adding a manufacturing site for an oral tablet. Identify applicable classification conditions, supporting data, related changes, and implementation constraints. Cite current variations guidance and flag information needed to confirm the route.

    Open Workbench
  • Workbench quick task · Quality & GMPNo documents needed

    Prepare for a GMP inspection

    Create an eight-week preparation plan for an oral solid dose site.

    See the prompt

    Create an eight-week preparation plan for an EU GMP inspection of an oral solid dose manufacturing site. Prioritise quality-system reviews, documentation, facility walkthroughs, and mock interviews. Cite applicable guidance and separate general preparation from checks requiring site records.

    Open Workbench
  • Workbench quick task · Quality & GMPNo documents needed

    Check supplier qualification evidence

    Learn what GMP certificates establish and what still needs review.

    See the prompt

    Create a supplier qualification checklist for an EU finished-product contract manufacturer. Explain how to use EudraGMDP records, verify certificate scope and dates, and identify limitations of public records. List additional evidence needed from the supplier and cite official guidance.

    Open Workbench
  • Workbench quick task · Quality & GMPUses your documents

    Review Annex 1 gaps

    Assess a contamination control strategy against relevant expectations.

    See the prompt

    Review the attached contamination control strategy and related SOPs against applicable EU GMP Annex 1 expectations. Produce a gap table with document references, relevant guidance sections, potential impact, and proposed actions. Identify areas that require site evidence or an on-site assessment.

    Open Workbench
  • Workbench quick task · Quality & GMPUses your documents

    Evaluate CAPA effectiveness

    Check whether the evidence supports the root cause and closure.

    See the prompt

    Review the attached deviation investigation, CAPA record, and effectiveness-check results. Assess whether actions address the documented root cause and whether closure is supported by evidence. Flag recurrence risks, missing evidence, and follow-up checks with references to the records.

    Open Workbench
Why Regunaut

Quality evidence checked against the guidance

Checklists from the guidance

Plans and checklists are built from EU GMP guidance and cite it, so each item can be traced to its source.

Your records, read in full

Gap tables point to the page of your document and the guidance section, and separate gaps from points that need evidence from the site.

Site and dossier kept in step

The same site check feeds the variation that adds the site, so the certificate is confirmed before the submission is drafted.

Related on Regunaut

Check your next site with the guidance beside it

See Workbench and Alerts on your own sites and suppliers in a 30-minute walkthrough.